Bringing Cognitive Health into the Digital Age

The Boston Cognitive Assessment (BoCA™) was originally developed by neuroscientist Dr. Andrey Vyshedskiy, PhD, as part of his academic research into brain function and cognitive health. What began as a tool to support peer-reviewed studies has since gained global adoption — with hundreds of thousands of assessments completed worldwide.
While BoCA™ is now commercially available as part of Boston Cognitive’s broader Boston Cognitive digital platform, it remains free for academic use, continuing its mission of advancing open, science-based research in cognition.

Boston Cognitive Screen™

A free self-administered cognitive screening tool for patients that can be taken remotely or in-clinic.

Boston Cognitive Assessment (BoCA™)

A state-of-the-art digital tool for accurate cognitive screening and measurement.

Boston Cognitive Care Plan™

Personalized, data-driven care plans to support cognitive health management.

Our Journey

Our commitment to cognitive health began with AlzLife, our pioneering brain training platform. By combining 40Hz light and sound stimulation with targeted cognitive exercises, AlzLife aimed to support brain function by restoring the brain’s natural 40Hz gamma rhythm — setting the foundation for all future developments.

This experience inspired neuroscientist Andrey Vyshedskiy, PhD, to develop BoCA™. Originally built for research, BoCA™ quickly gained global adoption, helping assess cognitive function in hundreds of thousands of individuals. 

We then introduced BellCurveAndMe, an early direct-to-consumer initiative designed to help individuals self-monitor cognitive health over time. This launch gave us broad insights across diverse populations and helped refine our clinical and digital strategies.

Today, Boston Cognitive brings these innovations together under one roof. We offer a comprehensive set of tools to screen, measure, and manage cognitive health—serving clinicians, researchers, and individuals alike. Our solutions form a continuum of care: from preventive wellness and self-directed trials to advanced clinical workflows, all grounded in science and built for impact.

Our Team

Our interdisciplinary leadership team brings together expertise in Science, Technology, Medicine, and Business Development

Dr. Andrey Vyshedskiy, PhD., Neuroscience

Neuroscientist with a Ph.D. from Neuroscience Boston University, Dr. Vyshedskiy has led research across neuroscience and psychology, founded successful companies, and developed FDA-approved medical devices. With over 100 scientific publications and numerous awards from the NSF, NIH, and DOD, his work has significantly advanced the field of cognitive science.

Andrei Savchenko, Technology

Versatile technical leader and architect with extensive experience helping startups turn ideas into impactful software. Andrei specializes in full-stack agile development and cloud architecture, focusing on building efficient, scalable solutions that address real-world problems in healthcare technology.

Dr. Mikhail Kogan, MD., Medicine

A pioneer in Integrative Geriatrics Medicine, Dr. Kogan is the chief editor of “Integrative Geriatric Medicine” and a frequent international speaker on healthy aging and neurodegenerative diseases. He serves as medical director of the GW Center for Integrative Medicine and has founded several innovative medical programs. Dr. Kogan’s expertise in integrative approaches to cognitive health significantly enhances Boston Cognitive’s mission.

Footnotes

1 University of Michigan’s Natonal Poll on Healthy Aging (NPHA), 2023.

2 Alzheimer’s Dement. 2021;17:1231–1243.

3 Based upon current National Correct Coding Initiative (NCCI) edits. Please check with your local payor policy.

4 National Average Payment Amount

5  https://health.gov/healthypeople/objectives-and-data/browse-objectives/dementias/reduce-proportion-preventable-hospitalizations-older-adults-dementia-dia-02

6 Journal of Palliative Medicine Volume 21, Number 4, 2018

7  https://www.cms.gov/files/document/2024-announcement-pdf.pdf